Does Bilateral Renal Agenesis have a cure?

Currently, there is no cure for Bilateral Renal Agenesis (BRA), a condition characterized by the total absence of kidney development in a fetus. Because the kidneys are essential for fetal lung development and life-sustaining waste filtration, the condition is typically fatal shortly after birth; however, ongoing research into fetal medicine and regenerative therapies aims to improve outcomes for affected families.

Is there a cure for Bilateral Renal Agenesis?

There is no medical or surgical cure for Bilateral Renal Agenesis, as the condition results in the complete failure of kidney formation during early gestation. Current clinical management focuses on palliative care for the newborn, as the lack of kidneys prevents the production of amniotic fluid, which is necessary for the proper development of the fetal lungs, a condition known as Potter sequence.

What are the current management strategies?

While we cannot cure Bilateral Renal Agenesis, medical teams focus on supportive care and prenatal counseling. Management strategies include:

• Prenatal monitoring: Serial ultrasounds to assess fetal development.


• Amnioinfusion: Experimental procedures to replace amniotic fluid, though this does not restore kidney function.


• Neonatal palliative care: Providing comfort-focused care for newborns affected by Bilateral Renal Agenesis.


• Genetic counseling: Assessing the risk of recurrence in future pregnancies, which is estimated at 3% to 5% for parents who have had one affected child.

What does the future of research look like?

Researchers are investigating the genetic pathways involved in kidney organogenesis, such as mutations in the RET or UPK3A genes, which may contribute to Bilateral Renal Agenesis. While gene therapy and stem cell-derived bioengineered kidneys are in early experimental stages, they are not yet viable clinical options. Current research is heavily focused on understanding the molecular triggers of renal agenesis to eventually provide preventative interventions.

How can families stay informed?

Because Bilateral Renal Agenesis is a rare and complex condition, it is vital to stay connected with specialists and the 19 members of our DiseaseMaps.org community who share lived experiences. Clinical trials for related renal developmental disorders are tracked through the NIH ClinicalTrials.gov registry.

Next steps

• Consult with a board-certified clinical geneticist to understand the underlying causes of Bilateral Renal Agenesis in your family.


• Connect with the DiseaseMaps.org community to share experiences and find emotional support.


• Review the latest research updates via the NIH Genetic and Rare Diseases (GARD) Information Center.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Bilateral Renal Agenesis


• Orphanet: Renal Agenesis (ORPHA:777)


• OMIM (Online Mendelian Inheritance in Man): Renal Agenesis, Bilateral (Entry #267400)


• National Kidney Foundation: Pediatric Kidney Research Updates